Atorvastatin Calcium
Product Images NDC 53002-6440

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-6440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph comparing the cumulative incidence (%) over years for Atorvastatin versus Placebo. The graph shows two lines: a solid line for Atorvastatin and a dashed line for Placebo, with incidence increasing over approximately 3.5 years. Statistical values HR=0.64 (0.50-0.83) and p=0.0005 are noted on the graph.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A cumulative hazard line graph comparing Atorvastatin and placebo over four years of follow-up. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio and statistical significance details for Atorvastatin versus placebo.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing the percentage of subjects experiencing a major cardiovascular event over time (years) comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The y-axis represents the percentage of subjects, while the x-axis shows time to first major cardiovascular endpoint up to 5 years. The graph includes a hazard ratio (HR) of 0.78 (0.69-0.89) with a p-value of 0.0002, indicating a comparison between the two dosages.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium, showing its molecular arrangement including phenyl rings, fluorine substitution, hydroxyl groups, and calcium ion complex with water molecules.*

FDA Label Image

Label Image (Lbl530026440)

Packaging label for Atorvastatin Calcium 40mg tablets by RPK Pharmaceuticals, Inc. The label indicates a quantity of 100 tablets with dosing instructions of one tablet daily. The label includes directions, storage information, barcodes, and billing NDC numbers, alongside spaces for patient and prescription information. The label emphasizes prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.